Real-world data of cardiovascular disease in patients with metabolic dysfunction-associated fatty liver disease based on medical claim database in Japan

被引：0
|
作者：
Yoneda, Masato [1 ]
Yamamoto, Takuma [2 ]
Honda, Yasushi [1 ]
Kobayashi, Takashi [1 ]
Nogami, Asako [1 ]
Iwaki, Keidai [1 ]
Kessoku, Takaomi [1 ]
Saito, Satoru [1 ]
Nakajima, Atsushi [1 ]
机构：
[1] Yokohama City Univ, Dept Gastroenterol & Hepatol, Yokohama, Kanagawa, Japan
[2] Kowa Co Ltd, Product Mkt Dept, Cardiovasc & Diabet, Tokyo, Japan
来源：
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY | 2021年 / 36卷
关键词：
MAFLD; NAFLD; CVD; big data;
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
PP-0143
引用
收藏
页码：128 / 128
页数：1
相关论文
共 50 条
  • [1] REAL-WORLD DATA OF RISK OF CARDIOVASCULAR DISEASE IN PATIENTS WITH NONALCOHOLIC FATTY LIVER DISEASE BASED ON MEDICAL BIG DATA IN JAPAN
    Yoneda, Masato
    Imajo, Kento
    Ogawa, Yuji
    Honda, Yasushi
    Saito, Satoru
    Nakajima, Atsushi
    Yamomoto, Takuma
    HEPATOLOGY, 2020, 72 : 989 - 990
  • [2] Metabolic Dysfunction-Associated Fatty Liver Disease, Statins, and Atherosclerotic Cardiovascular Disease
    Chang, Hui-Chin
    Gau, Shuo-Yan
    AMERICAN JOURNAL OF MEDICINE, 2024, 137 (01): : E14 - E14
  • [3] Metabolic Dysfunction-Associated Fatty Liver Disease Better Predicts Incident Cardiovascular Disease
    Jeong, Seogsong
    Oh, Yun Hwan
    Choi, Seulggie
    Chang, Jooyoung
    Kim, Sung Min
    Son, Joung Sik
    Lee, Gyeongsil
    Kim, Won
    Park, Sang Min
    GUT AND LIVER, 2021, : 589 - 598
  • [4] Metabolic Dysfunction-Associated Fatty Liver Disease, Statins, and Atherosclerotic Cardiovascular Disease Reply
    Yeoh, Aaron
    Cheung, Ramsey
    Ahmed, Aijaz
    Chitnis, Amit S.
    Do, Albert
    Wong, Robert J.
    AMERICAN JOURNAL OF MEDICINE, 2024, 137 (01): : E15 - E15
  • [5] Metabolic dysfunction-associated fatty liver disease and cardiovascular disease: A meta-analysis
    Wen, Wen
    Li, Hong
    Wang, Chunyi
    Chen, Chen
    Tang, Jiake
    Zhou, Mengyun
    Hong, Xuwei
    Cheng, Yongran
    Wu, Qi
    Zhang, Xingwei
    Feng, Zhanhui
    Wang, Mingwei
    FRONTIERS IN ENDOCRINOLOGY, 2022, 13
  • [6] Metabolic dysfunction-associated fatty liver disease and implications for cardiovascular risk and disease prevention
    Xiao-Dong Zhou
    Jingjing Cai
    Giovanni Targher
    Christopher D. Byrne
    Michael D. Shapiro
    Ki-Chul Sung
    Virend K. Somers
    C. Anwar A. Chahal
    Jacob George
    Li-Li Chen
    Yong Zhou
    Ming-Hua Zheng
    Cardiovascular Diabetology, 21
  • [7] Metabolic dysfunction-associated fatty liver disease and implications for cardiovascular risk and disease prevention
    Zhou, Xiao-Dong
    Cai, Jingjing
    Targher, Giovanni
    Byrne, Christopher D.
    Shapiro, Michael D.
    Sung, Ki-Chul
    Somers, Virend K.
    Chahal, C. Anwar A.
    George, Jacob
    Chen, Li-Li
    Zhou, Yong
    Zheng, Ming-Hua
    CARDIOVASCULAR DIABETOLOGY, 2022, 21 (01)
  • [8] METABOLIC DYSFUNCTION-ASSOCIATED FATTY LIVER DISEASE AND ITS EFFECT ON CARDIOVASCULAR DISEASE RISK IN PATIENTS WITH HCV
    Elgretli, Wesal
    Shengir, Mohamed
    Sasson, Solomon
    Ballesteros, Luz Ramos
    Wong, Philip
    Chen, Tianyan
    Deschenes, Marc
    Sebastiani, Giada
    HEPATOLOGY, 2023, 78 : S1010 - S1011
  • [9] Atherosclerotic cardiovascular disease risk difference in metabolic dysfunction-associated fatty liver disease and nonalcoholic fatty liver disease
    Tamaki, Nobuharu
    Kurosaki, Masayuki
    Higuchi, Mayu
    Izumi, Namiki
    HEPATOLOGY RESEARCH, 2021, 51 (11) : 1172 - 1173
  • [10] Metabolic dysfunction-associated fatty liver disease and atherosclerotic cardiovascular disease risk: Dual aetiology or metabolic dysfunction?
    Ma, Tianyi
    Yuan, Huawei
    Guo, Zhanfang
    LIVER INTERNATIONAL, 2024,
12345